Translational PsychiatryGenetic & Genomic MedicinePeer-reviewed journal article
Genetic liability to major psychiatric disorders contributes to multi-faceted quality of life outcomes in children and adults
Yingjie ShiiD, Nina Roth MotaiD, Barbara FrankeiD, Emma SprooteniD
Abstract
ImportancePsychiatric disorders can have an immense impact on socioeconomic, physical, and social-psychological facets of life. Psychiatric disorders are also highly heritable. Under a liability threshold model, an important question arises as to what extent genetic liability for psychiatric disorders relates to, and possibly impacts on, different aspects of quality of life in the general population. ObjectiveTo characterize the link between psychiatric genetic liability and diverse aspects of quality of life in childhood and adulthood. Design, setting, and participantsWe used data from two multi-site, population-based cohorts, i.e. preadolescent children in the USA enrolled at age 9-10 years from the Adolescent Brain Cognitive Development (ABCD) study (N=4,645) and white British adults between age 40-69 years from the UK Biobank (UKB) study (N=377,664). Due to the current limitations of our genetic methods, only data from unrelated individuals of European descent could be included. Main outcomes and measuresTo derive robust measures capturing multiple domains of quality of life in each of the cohorts, we integrated an array of measurements of academic, economic, and physical status, as well as social well-being, in a second-level three-factor confirmatory factor analysis. The genetic liabilities to seven major psychiatric disorders were quantified by a set of polygenic scores (PGSs) derived from the largest genome-wide association studies to date, independent of the target cohorts, of major depressive disorder (MDD, N=142k-173k), anxiety disorders (ANX, N=22k-144k), attention-deficit/hyperactivity disorder (ADHD, N=226k), autism spectrum disorder (ASD, N=55k), schizophrenia (SCZ, N=130k), bipolar disorder (BIP, N=353k-414k), and cannabis use disorder (CUD, N=384k). Using general linear models we assessed associations between PGSs and the estimated latent factors, controlling for age, sex, site, genotyping batch, plate, and genetic ancestry. ResultsIn each cohort, three latent factors indexing distinct but correlated quality of life domains, (1) educational performance and cognition (Edu, in ABCD) / social economic status (SES, in UKB), (2) physical health (Hea), (3) adverse social experience (Adv, in ABCD) / social well-being (Soc, in UKB), were estimated with excellent model fit indices. In addition, a general factor was derived that captured the covariances between the three latent factors (QoL). In the ABCD cohort, ADHD-PGS was significantly associated with Edu ({beta} = -0.13, t = -8.29, p = 1.53e-16), Adv ({beta} = -0.09, t = -5.79, p = 7.81e-09), and general QoL ({beta} = -0.14, t = -8.74, p = 3.37e-18) factors. In the UKB cohort, all examined disorder PGSs were significantly associated with the general QoL latent factor and at least one first-order subdomain, with ADHD-PGS ({beta} = -0.06 [~] -0.10, t = -29.1 [~] -52.5, p < 5.91e-186) and MDD-PGS ({beta} = -0.04 [~] -0.07, t = -23.8 [~] -36.3, p < 3.63e-125) showing the largest effects. Conclusions and relevanceThe present study reveals an inverse relationship between psychiatric genetic liabilities and multiple quality of life metrics, with ADHD-associated genetic risk being the main contributor in both children and adults, and MDD additionally showing effects in adults. All effect sizes observed were small, as expected. Understanding potential real-world outcomes of quantitative measures of disorder-related genetic risks in the general population can provide a scientific foundation for societal intervention and policy-making processes, with profound implications for promoting a flourishing society.
- organism: human
- assay: GWAS summary statistics
- research focus: gene regulatory network inference
- approach: statistical model
- Citations
- 6
- FWCI
- 2.35
- Field percentile
- top 12%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Using genetics to examine a general liability to childhood psychopathology
Lucy Riglin, Ajay K. Thapar, … Anita Thapar·Behavior GeneticsPeer-reviewed·Dec 11, 2019
- Application of polygenic scores to a deeply phenotyped sample enriched for substance use disorders reveals extensive pleiotropy with psychiatric and medical traits
Emily E. Hartwell, Zeal Jinwala, … Rachel L. Kember·NeuropsychopharmacologyPeer-reviewed·Jul 23, 2024
- Multi-polygenic scores in psychiatry: from disorder-specific to transdiagnostic perspectives
Yingjie Shi, Emma Sprooten, … Nina Roth Mota·American Journal of Medical Genetics Part B Neuropsychiatric GeneticsPeer-reviewed·Jun 19, 2023
- Phenotypic and Genetic Markers of Psychopathology in a Population-Based Sample of Older Adults
Arianna M. Gard, Erin Bakshis Ware, … Colter M. Mitchell·Translational PsychiatryPeer-reviewed·Apr 24, 2021
- Phenome-wide and Genome-wide Analyses of Quality of Life in Schizophrenia
Raha Pazoki, Bochao Danae Lin, … Jurjen Justin Luykx·BJPsych OpenPeer-reviewed·Dec 9, 2020
- The relationship between genotype- and phenotype-based estimates of genetic liability to psychiatric disorders, in practice and in theory.
Morten Dybdahl Krebs, Vivek Appadurai, … Andrew Joseph Schork·The American Journal of Human GeneticsPeer-reviewed·Dec 22, 2025